LDLR and metabolic dysfunction-associated steatotic liver disease: Further, studies have shown that Elovl6 promotes NAFLD, whereas absence of Elovl6 ameliorates steatohepatitis in a lithogenic diet-fed LDL receptor-deficient mouse model [53, 54].